Developer docs
API playgroundTry for free, no card

Search company profiles

Nanox

Full company profile

uuid0021163

Namestring
Nanox
Legal namestring
Nano-X Imaging Ltd.
Company typeenum
Public
Founded yearint
2019
Descriptiontext

Nano-X Imaging Ltd. (NASDAQ: NNOX) is a publicly traded medical technology company developing and commercializing tomographic imaging devices and complementary teleradiology services for healthcare providers. The company's hardware product produces cross-sectional diagnostic images using a proprietary design positioned as an alternative to conventional CT imaging, while its services offering provides remote radiology interpretation to support reading workloads at customer sites.

The target customer base consists of healthcare providers in the United States, with named segments including hospitals, clinics, and medical imaging centers. The bundled hardware-plus-services model implies a revenue mix combining device sales, placement/usage fees, and per-study interpretation charges, though the input material does not break out price points, contract structures, or installed-base metrics.

Per available market data, the company has reported revenue of approximately $13.02 million and trades on NASDAQ at $5.16, with a published 12-month price target of $5.00. The company also references AI/ML-powered imaging informatics as part of its product surface, without further technical disclosure in the supplied material. Note: a separate, unsupported firmographics block describes a distinct "Nanox" entity tied to nanoxnutriceuticals.com; that data lacks source attribution and was not used in this analysis.

Short descriptiontext

Nano-X Imaging Ltd. (NASDAQ: NNOX) develops proprietary tomographic imaging devices and provides teleradiology services to U.S. healthcare providers, including hospitals, clinics, and medical imaging centers. The company sells diagnostic imaging hardware bundled with remote radiology interpretation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersQuebec, Canada
HQ citystring
Quebec
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical imaging devices, tomographic imaging, teleradiology services, diagnostic imaging, radiology informatics
Industry2 codes
PRIMARYHLAHABAB
Computed Tomography (CT) Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Equipment
Social media profiles2 records
Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nano-X Imaging develops tomographic (cross-sectional) imaging hardware devices for medical diagnostics and pairs them with teleradiology services that enable remote interpretation of medical images by radiologists. The company offers an integrated medical imaging solution targeting hospitals, clinics, and imaging centers that need diagnostic imaging capability and remote radiology expertise.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Nanox offers a portfolio of medical imaging solutions consisting of tomographic imaging devices and teleradiology services. The company develops hardware-based tomographic imaging technology for medical diagnostics combined with remote radiology interpretation services, providing an integrated approach to medical imaging.

Product and service2 records
1Tomographic Imaging Devices
CategoryMedical Imaging Hardware
2Teleradiology Services
CategoryRadiology Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CT, MRI, ultrasound, and X-ray OEM focused on diagnostic imaging. Closely aligned to Nano-X in the CT / tomographic imaging category, competing for the same hospital radiology customers.

TypeBroad incumbent
Description

Dominant medical imaging OEM offering CT, MRI, X-ray, and ultrasound systems globally. Directly comparable as an incumbent in tomographic / cross-sectional imaging, but operates across a much broader portfolio beyond Nano-X's narrow focus.

TypeDirect peer
Description

Largest U.S. outpatient imaging network and a major provider of teleradiology services. Directly comparable to Nano-X on the teleradiology and diagnostic-imaging-center side of the business model.

TypeDirect peer
Description

Specialist in women's health imaging (including tomosynthesis) and diagnostics. Comparable as a focused medical-imaging device maker competing in cross-sectional imaging, though concentrated in breast and women's health.

TypeRegional player
Description

Korean OEM producing ultrasound and diagnostic imaging equipment, strong in APAC. Comparable as a regional imaging OEM with overlapping modalities (CT/ultrasound) and similar enterprise sales motion into hospitals.

TypeBroad incumbent
Description

Global leader in CT, MRI, and imaging IT (syngo). Comparable as a major incumbent in tomographic imaging with deep hospital installed bases, alongside adjacent enterprise imaging and teleradiology offerings.

TypeEmerging player
Description

Handheld, semiconductor-based ultrasound company with AI-enabled imaging software. Comparable as an emerging player using novel hardware + AI-software to disrupt traditional imaging modalities, similar to Nano-X's bundled AI informatics strategy.

TypeEmerging player
Description

Developer of portable, point-of-care MRI systems. Comparable as a small-cap public med-tech challenging conventional imaging economics with novel hardware architectures — analogous to Nano-X's disruptive tomographic device thesis.

TypeBroad incumbent
Description

Maker of X-ray, CT, endoscopy, and healthcare IT systems. Comparable as a broad imaging incumbent whose X-ray and CT product lines overlap directly with Nano-X's tomographic devices.

TypeBroad incumbent
Description

Imaging, diagnostic, and connected-care business with strong CT and radiology informatics exposure. Comparable as a broad incumbent with overlapping tomographic imaging and clinical workflow software.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nanox

Medical Imaging Equipmentnanoxnutriceuticals.com

Nano-X Imaging Ltd. (NASDAQ: NNOX) develops proprietary tomographic imaging devices and provides teleradiology services to U.S. healthcare providers, including hospitals, clinics, and medical imaging centers. The company sells diagnostic imaging hardware bundled with remote radiology interpretation.

What Nanox does

Nano-X Imaging Ltd. (NASDAQ: NNOX) is a publicly traded medical technology company developing and commercializing tomographic imaging devices and complementary teleradiology services for healthcare providers. The company's hardware product produces cross-sectional diagnostic images using a proprietary design positioned as an alternative to conventional CT imaging, while its services offering provides remote radiology interpretation to support reading workloads at customer sites.

The target customer base consists of healthcare providers in the United States, with named segments including hospitals, clinics, and medical imaging centers. The bundled hardware-plus-services model implies a revenue mix combining device sales, placement/usage fees, and per-study interpretation charges, though the input material does not break out price points, contract structures, or installed-base metrics.

Per available market data, the company has reported revenue of approximately $13.02 million and trades on NASDAQ at $5.16, with a published 12-month price target of $5.00. The company also references AI/ML-powered imaging informatics as part of its product surface, without further technical disclosure in the supplied material. Note: a separate, unsupported firmographics block describes a distinct "Nanox" entity tied to nanoxnutriceuticals.com; that data lacks source attribution and was not used in this analysis.

Nanox firmographics

Firmographics
Name
Nanox
Legal name
Nano-X Imaging Ltd.
Website
https://nanoxnutriceuticals.com
Company type
Public
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Nano-X Imaging Ltd. (NASDAQ: NNOX) develops proprietary tomographic imaging devices and provides teleradiology services to U.S. healthcare providers, including hospitals, clinics, and medical imaging centers. The company sells diagnostic imaging hardware bundled with remote radiology interpretation.
Ownership category
akta.pro rank

Nanox industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAB
Computed Tomography (CT) Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Medical imaging devices
  • Tomographic imaging
  • Teleradiology services
  • Diagnostic imaging
  • Radiology informatics

Where Nanox is headquartered

Location

Headquarters

HQ city
Quebec
HQ country
Canada
HQ region
North America

Markets served

Nanox business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Nanox product offering

Product offering

Core offering

Nano-X Imaging develops tomographic (cross-sectional) imaging hardware devices for medical diagnostics and pairs them with teleradiology services that enable remote interpretation of medical images by radiologists. The company offers an integrated medical imaging solution targeting hospitals, clinics, and imaging centers that need diagnostic imaging capability and remote radiology expertise.

Product overview

Nanox offers a portfolio of medical imaging solutions consisting of tomographic imaging devices and teleradiology services. The company develops hardware-based tomographic imaging technology for medical diagnostics combined with remote radiology interpretation services, providing an integrated approach to medical imaging.

Differentiator

Problem solved

Functional benefit

Products and services

  • Tomographic Imaging Devices
  • Teleradiology Services

Companies that use Nanox

Customer profile

Segments1 record

Ideal customer profiles1 record

Nanox technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Nanox partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves3 records

Expansion highlights3 records

Nanox competitors and assessment

Company assessment

Direct peers

  • Canon Medical Systems: CT, MRI, ultrasound, and X-ray OEM focused on diagnostic imaging. Closely aligned to Nano-X in the CT / tomographic imaging category, competing for the same hospital radiology customers.
  • RadNet: Largest U.S. outpatient imaging network and a major provider of teleradiology services. Directly comparable to Nano-X on the teleradiology and diagnostic-imaging-center side of the business model.
  • Hologic: Specialist in women's health imaging (including tomosynthesis) and diagnostics. Comparable as a focused medical-imaging device maker competing in cross-sectional imaging, though concentrated in breast and women's health.

Broad incumbents

  • GE HealthCare: Dominant medical imaging OEM offering CT, MRI, X-ray, and ultrasound systems globally. Directly comparable as an incumbent in tomographic / cross-sectional imaging, but operates across a much broader portfolio beyond Nano-X's narrow focus.
  • Siemens Healthineers: Global leader in CT, MRI, and imaging IT (syngo). Comparable as a major incumbent in tomographic imaging with deep hospital installed bases, alongside adjacent enterprise imaging and teleradiology offerings.
  • Fujifilm Healthcare: Maker of X-ray, CT, endoscopy, and healthcare IT systems. Comparable as a broad imaging incumbent whose X-ray and CT product lines overlap directly with Nano-X's tomographic devices.
  • Philips Healthcare: Imaging, diagnostic, and connected-care business with strong CT and radiology informatics exposure. Comparable as a broad incumbent with overlapping tomographic imaging and clinical workflow software.

Regional players

  • Samsung Medison: Korean OEM producing ultrasound and diagnostic imaging equipment, strong in APAC. Comparable as a regional imaging OEM with overlapping modalities (CT/ultrasound) and similar enterprise sales motion into hospitals.

Emerging players

  • Butterfly Network: Handheld, semiconductor-based ultrasound company with AI-enabled imaging software. Comparable as an emerging player using novel hardware + AI-software to disrupt traditional imaging modalities, similar to Nano-X's bundled AI informatics strategy.
  • Hyperfine: Developer of portable, point-of-care MRI systems. Comparable as a small-cap public med-tech challenging conventional imaging economics with novel hardware architectures — analogous to Nano-X's disruptive tomographic device thesis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Nanox social profiles

Digital presence

Nanox financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nanox leadership team

Management profile

Number of profiles

Profiles1 record

Nanox funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nanox M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanox

What does Nanox do?

Nano-X Imaging develops tomographic (cross-sectional) imaging hardware devices for medical diagnostics and pairs them with teleradiology services that enable remote interpretation of medical images by radiologists. The company offers an integrated medical imaging solution targeting hospitals, clinics, and imaging centers that need diagnostic imaging capability and remote radiology expertise.

Is Nanox a public or private company?

Nanox is a public company. It is classified as public and is currently operating.

When was Nanox founded?

Nanox was founded in 2019. It employs 1 to 10 people.

Where is Nanox based?

Nanox is headquartered in Quebec, Canada, in the North America region.

Who are Nanox's main competitors?

Direct peers on record are Canon Medical Systems, RadNet and Hologic. Broad incumbents are GE HealthCare, Siemens Healthineers, Fujifilm Healthcare and Philips Healthcare. Samsung Medison is listed as a regional player. Emerging players are Butterfly Network and Hyperfine.

Does Nanox have an API?

No public API is recorded for Nanox.

What industry is Nanox in?

Nanox's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAB, Computed Tomography (CT) Systems, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileNANO-X DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important August 11 Deadline in Securities Class Action - NNOXThe Rosen Law Firm has issued a notice reminding investors of Nano-X Imaging Ltd. of the August 11, 2026 deadline to file as lead plaintiff in a securities class action lawsuit filed against the company. According to the complaint, defendants allegedly made false and misleading statements regarding the company's operational efficiency and product demand when in reality Nano-X was experiencing poor manufacturing alignment, significantly increased operating expenses, and cash burn. When the true details entered the market, investors allegedly suffered damages as a result of the materially false public statements.Quiver QuantitativeNanox.AI Optimizes Medical Imaging AI Framework for Intel Core Ultra Processors Using OpenVINO Toolkit | NNOX Stock NewsNanox AI Ltd., a subsidiary of Nano-X Imaging Ltd., announced the optimization of its medical imaging AI application framework for Intel Core Ultra processors using Intel's OpenVINO toolkit, enabling healthcare organizations to run AI-powered CT scan analysis on-premise. The framework supports edge inference for detecting chronic conditions including cardiac, liver, and bone health issues while maintaining data within the healthcare facility's own infrastructure. The successful optimization demonstrates the potential for local AI processing in medical imaging, reducing dependence on cloud connectivity while supporting hospital infrastructure requirements.Stock TitanNanox.AI Optimizes Imaging AI Framework With OpenVINONanox AI Ltd., a subsidiary of Nano-X Imaging Ltd., announced the optimization of its medical imaging AI application framework for Intel Core Ultra processors using Intel's OpenVINO toolkit, designed for on-premise edge deployment within healthcare facilities. The framework enables healthcare organizations to evaluate and deploy CT imaging AI applications while keeping imaging data within their own infrastructure, supporting local inference and reducing dependence on cloud connectivity. Nanox.AI solutions analyze routine medical CT scans to identify findings correlated with chronic conditions in cardiac, liver, and bone health areas.PR NewswireNano-X Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud LawsuitA class action lawsuit has been filed against Nano-X Imaging Ltd. regarding alleged false and misleading statements made by the company during the period from March 31, 2025, to April 17, 2026. The lawsuit claims the company overstated operational efficiencies and demand for its products, leading to increased costs and potential restructuring.NewsfileNANO-X DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important August 11 Deadline in Securities Class Action - NNOXRosen Law Firm has issued a reminder to investors of Nano-X Imaging Ltd. regarding an upcoming August 11, 2026, deadline to join a securities class action related to alleged false and misleading statements by Nano-X during the 2025-2026 period. The lawsuit claims that Nano-X overstated its operational efficiency and demand for its products, which led to investor damages.FinancialContent Business PageNANO-X DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class ActiThe Rosen Law Firm is urging Nano-X Imaging Ltd. investors who purchased shares between March 31, 2025, and April 17, 2026, to secure legal counsel before the August 11, 2026, lead plaintiff deadline in a pending securities class action. The lawsuit alleges that Nano-X made false statements regarding operational efficiency and demand while concealing increased operating expenses and cash burn. Investors may be entitled to compensation through a contingency fee arrangement if they join the action.NewsfileBronstein, Gewirtz & Grossman LLC Urges Nano-X Imaging Ltd. Investors to Act: Class Action Filed Alleging Investor HarmBronstein, Gewirtz & Grossman LLC filed a class action lawsuit against Nano-X Imaging Ltd. and its officers alleging violations of federal securities laws for the period between March 31, 2025, and April 17, 2026. The complaint claims the company made materially false statements regarding operational efficiency and demand while hiding increased operating expenses and cash burn rates. Investors are encouraged to join the case or request lead plaintiff status by August 11, 2026.PR NewswireNNOX Deadline: NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud LawsuitRosen Law Firm has filed a securities class action lawsuit against Nano-X Imaging Ltd. (NASDAQ: NNOX) alleging that the company made false and misleading statements about its operational efficiency and product demand between March 31, 2025 and April 17, 2026. The lawsuit claims Nano-X failed to disclose that its production and manufacturing operations were poorly aligned with demand, resulting in significantly increased operating expenses and cash burn. Investors who purchased Nano-X securities during the class period have until August 11, 2026 to move to serve as lead plaintiff in the litigation.GlobeNewswireShareholders who lost money in shares Nano-X Imaging Ltd. (NASDAQ: NNOX) should contact Wolf Haldenstein ImmediatelyWolf Haldenstein Adler Freeman & Herz LLP announced a securities class action lawsuit against Nano-X Imaging Ltd. on behalf of investors who purchased securities between March 31, 2025 and April 17, 2026, alleging defendants made materially false and misleading statements about operational efficiency, product demand, and cash burn. The truth emerged on April 20, 2026, when Nano-X reported a Q4 2025 net loss of $33.4 million, including a $17.5 million impairment charge from restructuring its Korean chip manufacturing facility, causing the stock to fall 24.39% to $2.155 per share. The company's CFO also announced his resignation effective July 31, 2026.